Efficacy and safety of pitavastatin on bone metabolism in patients with hypercholesterolemia and low bone mass
Not Applicable
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0004114
- Lead Sponsor
- Seoul National University Bundang Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
<70 years-old menopausal females
- T-score: -1.5 ~ - 3.0
- Dyslipidemia
- C-telopeptide > 0.4 ng/mL or NTX > 16.5 nmolBCE/
Exclusion Criteria
-statin medication within 3 months
-glucocorticoid injection more than 1 week within 3 months
-use of thiazolidinedione or SGLT2-inhibitor
-malignancy under active treatment
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in C-telopeptide levels from baseline
- Secondary Outcome Measures
Name Time Method Change in C-telopeptide levels from baseline;Change in LDL-cholesterol levels from baseline;Change in LDL-cholesterol levels from baseline;Change in HbA1c levels from baseline;Change in osteocalcin levels from baseline;Change in NTX levels from baseline